Sands Capital Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Sands Capital Management, LLC
- $33 Billion
- Q2 2025
A detailed history of Sands Capital Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Sands Capital Management, LLC holds 3,943,485 shares of RARE stock, worth $111 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
3,943,485
Previous 4,163,561
5.29%
Holding current value
$111 Million
Previous $151 Million
4.89%
% of portfolio
0.43%
Previous 0.55%
Shares
9 transactions
Others Institutions Holding RARE
# of Institutions
363Shares Held
89MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$287 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$158 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$81.1 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$77.9 Million1.02% of portfolio
-
State Street Corp Boston, MA2.57MShares$72.3 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.97B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...